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The structures of a new crystal form of free Escherichia coli
uracil DNA glycosylase (UDG), containing four molecules in
the asymmetric unit, and two forms of its complex with the
proteinaceous inhibitor Ugi, containing two and four crystallo-
graphically independent complexes, have been determined. A
comparison of these structures and the already known crystal
structures containing UDG shows that the enzyme can be
considered to be made up of two independently moving
structural entities or domains. A detailed study of free and
DNA-bound human enzyme strengthens this conclusion. The
domains close upon binding to uracil-containing DNA,
whereas they do not appear to do so upon binding to Ugi.
The comparative study also shows that the mobility of the
molecule involves the rigid-body movement of the domains
superposed on ¯exibility within domains.
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PDB References: UDG, 1lqj,
r1lqjsf; UDG±Ugi, form I,
1lqg, r1lqgsf; UDG±Ugi,
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1. Introduction
Uracil DNA glycosylase (UDG) is an important DNA-repair
enzyme which recognizes and removes uracil occurring in
DNA owing to either incorporation of dUMP or spontaneous
deamination of cytosine and initiates the base-excision repair
pathway (David & Williams, 1998; McCullough et al., 1999).
UDG was the ®rst DNA glycosylase to be discovered and
puri®ed from E. coli (Lindahl, 1974; Lindahl et al., 1977) and
subsequently cloned (Duncan & Chambers, 1984) and
sequenced (Varshney et al., 1988). Although E. coli UDG
(EcUDG) has served as a prototype for much of the
biochemical studies, enzymes from herpes simplex virus type-1
and human were the ®rst to be X-ray analysed (Savva et al.,
1995; Savva & Pearl, 1995; Mol, Arvai, Sanderson et al., 1995;
Mol, Arvai, Slupphaug et al., 1995; Slupphaug et al., 1996;
Parikh et al., 1998). The X-ray determination of the E. coli
enzyme in complex with the proteinaceous inhibitor Ugi
encoded by Bacillus subtilis phage (PBS-1 or PBS-2) was ®rst
reported by our group (Ravishankar et al., 1998). Subse-
quently, X-ray studies on the enzyme and several complexes
were reported from two other laboratories (Putnam et al.,
1999; Xiao et al., 1999; Drohat et al., 1999; Werner et al., 2000).
The three-dimensional structures and the sequences show
UDG to be a highly conserved enzyme (Pearl, 2000). The
structural and other studies have also led to the proposal of a
common pinch±push±pull mechanism for the detection and
¯ipping out of uracil in the substrate for repair (Parikh et al.,
1998). According to this proposal, the initial lesion detection
occurs via a pinch mechanism involving three Ser-Pro-rich
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loops. Subsequently, the damaged nucleotide is ¯ipped out
through the DNA major groove into the enzyme active site by
a push±pull mechanism. The Leu intercalation loop, on
productive binding, moves about 4 AÊ , allowing the leucine
side chain to penetrate the DNA minor groove, causing the
complete ¯ipping of uridine. This pushing is accompanied by a
pull by the binding pocket that speci®cally recognizes the
uracil nucleotide by complementary active-site residues.
Recently, an additional role for this leucine has been
suggested in stabilization of the productive enzyme±substrate
complex (Handa et al., 2001). The closing of the active site
which occurs upon substrate binding distorts uracil and
deoxyribose in the ¯ipped-out nucleotide. The resulting strain
is relieved by glycosylic bond cleavage (Parikh, Walcher et al.,
2000).
Part of the work reported here is concerned with the
structures of a new crystal form of EcUDG and two forms of
its complex with Ugi. One of the two crystal forms of the
complex is new. The other is the same as reported previously,
but diffracts to higher resolution with more residues de®ned.
The crystal structure of the free enzyme contains four mole-
cules in the asymmetric unit, while there are two and four
crystallographically independent molecules in the two forms
of the complex. The new crystal form of the free enzyme has
the highest solvent content observed in crystals containing
UDG. Consequently, the resolution of the data is compara-
tively poor, but the molecules in it are less constrained by
packing interactions when involved in domain or segmental
motions. With the structure determinations reported here,
structural data on 20 crystallographically independent
EcUDG molecules, free as well as complexed with different
ligands in different environments, are available. They provide
a rich resource for analysing the mobility of the molecule and
its functional signi®cance. Such an analysis, presented here in
addition to the new structures, has yielded interesting results.
The conclusions are further strengthened by a detailed study
of the known structures of the free, Ugi-bound and DNA-
bound human enzyme.
2. Materials and methods
2.1. Crystallization
Free UDG was overexpressed and puri®ed from pTrcUng
(Handa et al., 2001). The UDG±Ugi complex was puri®ed
from a clone (pTrcUDG:Ugi1) containing the UDG and the
Ugi genes in tandem downstream of the Ptrc promoter with
TAG as the termination codon for the UDG ORF. The plas-
mids were overexpressed in E. coli TG1 carrying supE, which
results in low-level suppression of the UAG codon. The UDG±
Ugi complex whose structure was reported previously was
expressed from a similar construct which contained TAA as
the termination codon at the end of the UDG ORF (Roy et al.,
1998). Crystallization was carried out using the hanging-drop
method. Crystals of free UDG were grown by equilibrating
5 mg mlÿ1 protein in 20 mM Tris±HCl buffer pH 7.4
containing 100 mM NaCl against 15%(w/v) PEG 8000 in the
same buffer at 293 K. Crystals grew in 15 d to dimensions of
0.16 0.04 0.04 mm. Two crystal forms of the complex were
obtained from two different crystallization conditions. Crystals
of form I were grown from 10 mg mlÿ1 protein in 20 mM Tris±
HCl buffer pH 7.6, with 10%(w/v) PEG 1250 as the precipitant
at 293 K. Crystals of maximum dimensions 0.12  0.10 
0.08 mm took 32 weeks to grow. A solution of 10 mg mlÿ1
protein in 20 mM imidazole±maleate buffer pH 7.6 with
10%(w/v) PEG 4000 as the precipitant yielded crystals of form
II. The setup was initially incubated at 281 K for eight weeks
before being transferred to 293 K. After a period of 16 weeks,
crystals of dimensions 0.14  0.10  0.12 mm were obtained.
In all cases crystals appeared only very infrequently.
2.2. Data collection
Intensity data from all three crystals were collected at 293 K
on a MAR Research imaging plate with X-rays generated by a
Rigaku rotating-anode generator operating at 40 kV and
56 mA, using Cu K radiation. The data set in each case was
collected from a single crystal, even if it meant that comple-
teness was not as good as it could be, and was processed using
the DENZO/SCALEPACK suite of programs (Otwinowski,
1993). Data-collection statistics for both the free and complex
crystal forms are given in Table 1. The space group and unit-
cell parameters of form I of the complex are the same as those
of the structure reported earlier. However, the crystals now
diffracted better.
2.3. Structure solution and refinement
The structure solution of the crystals of free UDG turned
out to be extremely dif®cult. The data quality was poor and
processing indicated several possible hexagonal and trigonal
space groups. Therefore, a large number of molecular-
replacement calculations using AMoRe (Navaza, 1994) had to
be carried out with different space groups and search models
(PDB codes 1uug, 2uug, 1eui) before arriving at a solution
which eventually turned out to be correct. The solution used
the UDG molecule in the UDG±Ugi complex reported by
Table 1
Data-collection statistics.
Values in parentheses refer to the ®nal resolution shell.
Free
UDG±Ugi
(form I)
UDG±Ugi
(form II)
Space group P32 P212121 P21212
Unit-cell parameters
a (AÊ ) 125.21 51.16 98.76
b (AÊ ) 125.21 89.90 158.87
c (AÊ ) 90.05 141.78 91.22
Z 12 8 16
Solvent content (%) 67.8 45.0 50.1
Data resolution (AÊ ) 3.35 2.90 3.20
Final resolution shell 3.47±3.35 3.00±2.90 3.31±3.20
Total No. of re¯ections 38941 51769 94765
No. of unique re¯ections 20394 14803 21106
Completeness of data (%) 90.2 (94.8) 98.0 (98.2) 87.6 (79.3)
Rmerge (%) 15.4 (36.9) 11.0 (37.8) 16.7 (39.8)
Average I/(I) 6.9 (1.4) 7.1 (1.5) 9.2 (1.4)
Putnam et al. (1999) (PDB code 1uug) as the search model and
gave a correlation coef®cient and R factor of 0.395 and 0.403,
respectively, for data in the 15±4 AÊ resolution shell. It led to
acceptable packing of 12 molecules in the unit cell with space
group P32. Structure re®nement was carried out using
X-PLOR (BruÈ nger, 1992). The electron-density map calcu-
lated after rigid-body re®nement was used to rebuild the
model using FRODO (Jones, 1978). Non-crystallographic
symmetry restraints with an energy constant of 1256 kJ molÿ1
were applied in the subsequent re®nement. The NCS restraint
was progressively reduced in steps of 209 kJ molÿ1, each step
involving 15 steps of minimization. Only overall and group B
factors were re®ned throughout. Water molecules were
de®ned based on peaks with height greater than 3 in Fo ÿ Fc
maps and those with height 1 in 2Fo ÿ Fc maps. Omit-type
maps (Vijayan, 1980; Bhat & Cohen, 1984) were used to
con®rm the location of water molecules and to remove the
effects of any model bias. The structure of form I was re®ned
using the coordinates of the EcUDG±Ugi complex (PDB code
1eui) solved at 3.2 AÊ (Ravishankar et al., 1998), as the lattice
settings for both crystals were the same. The form II crystal
structure was determined by molecular replacement using
AMoRe. The EcUDG±Ugi complex reported by Putnam et al.
(1999) (PDB code 1uug) was used as the search model. The
correct solution was obtained with a correlation coef®cient of
73.9% and an R factor of 28.8%. The protocol used for
re®ning the structures of the complexes was similar to that
used in the case of the structure of free UDG. The re®nement
statistics for all three structures are given in Table 2.
2.4. Structural comparisons and helical parameters
ALIGN (Cohen, 1997) was used to carry out structural
superpositions. Difference distance matrices (Nishikawa et al.,
1972; Kundrot & Richards, 1987; Madhusudan & Vijayan,
1991) were used for structural comparisons. If the distance
between the C atom of the ith residue and that of the jth
residue in one structure is Rij and the corresponding distance
in another structure is R0ij, then the element dij in the differ-
ence distance matrix between the two is Rij ÿ R0ij.
Helical parameters were calculated using a slightly modi®ed
version of HELANAL (Kumar & Bansal, 1996).
3. Results and discussion
3.1. Overall structure
EcUDG, like the enzyme from other sources, is a classical
±± protein which has a small parallel four-stranded -sheet
(58±62, 119±123, 160±164 and 181±185), with II±I±III±IV
strand connectivity, at the centre of the molecule (Fig. 1). The
sheet is ¯anked by several helices. Four of the helices are ten
or more residues long (18±33, 87±99, 141±155 and 202±212),
while each of the remaining half a dozen helices contain six
residues or less. The lengths of the loops vary from two to 26
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Table 2
Re®nement parameters.
Free
UDG±Ugi
(form I)
UDG±Ugi
(form II)
Resolution limits used in re®nement (AÊ ) 20.0±3.35 20.0±2.90 15.0±3.20
Final R factor (%) 24.1 18.3 18.8
Rfree (%) 32.6 27.7 26.0
R.m.s. deviations from ideal
Bond lengths (AÊ ) 0.014 0.010 0.011
Bond angles () 1.9 1.7 1.6
Dihedral angles () 27.1 27.2 26.4
Improper angles () 0.91 0.83 0.95
Estimated coordinate error
from Luzzati plot (AÊ )
0.40 0.25 0.30
No. of protein atoms 7157 4611 9690
No. of water molecules 175 156 58
Figure 1
A ribbon representation of the EcUDG±Ugi complex, illustrating the
secondary-structure elements. The -helices and the -strands of the
enzyme molecule are coloured green and pink, respectively, while those
in the inhibitor molecule are coloured brown and cyan, respectively. The
four strands of UDG are labelled. The ®gure was generated using
MOLSCRIPT (Kraulis, 1991).
Table 3
Structures containing EcUDG used in the analysis.
PDB
code
Resolution
(AÊ )
Bound
ligand
No. of molecules
in asymmetric
unit
Solvent
content
(%) Reference
1uug 2.40 Ugi 2 52.7 Putnam et al. (1999)
2uug 2.60 Ugi 2 36.7 Putnam et al. (1999)
1eug 1.60 Ð 1 39.9 Xiao et al. (1999)
2eug 1.50 Uracil 1 35.5 Xiao et al. (1999)
3eug 1.43 Glycerol 1 36.5 Xiao et al. (1999)
4eug 1.40 Ð 1 39.9 Drohat et al. (1999)
5eug 1.60 Uracil 1 36.5 Drohat et al. (1999)
1lqg 2.90 Ugi 2 45.0 This study
1lqm 3.20 Ugi 4 50.1 This study
1lqj 3.35 Ð 4 67.8 This study
1¯z 2.30 ssDNA 1 46.8 Werner et al. (2000)
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residues. A groove made up of residues Gln63, Asn123,
Ser166, His187, Ser189, Leu191 and Ser192 is involved in
DNA binding, while the uracil-binding pocket involves Gln63,
Asp64, Tyr66, Phe77, Asn123 and His187. The binding region
of Ugi on UDG is the same as that which accommodates DNA
(Ravishankar et al., 1998; Putnam et al., 1999). The four
crystallographically independent molecules in the crystals of
free UDG and the six in the two forms of its complex with Ugi
have essentially the same structure. Also, the structures of the
free molecule and the complex derived from the present study
are very similar to those obtained previously. The free struc-
ture consists of residues 1±228, 1±226, 1±229 and 3±228 in
subunits A, B, C and D, respectively. Form I of the UDG±Ugi
complex consists of residues 3±228 and 2±225 in enzyme
molecules A and B, respectively, and 12±84 and 15±84 in the
corresponding inhibitor molecules. In the form II UDG±Ugi
complex, the enzyme molecules B and C contain residues
4±227, whereas A and D contain residues 4±226 and 2±226,
respectively. Residues 3±84 in molecules A and C, 2±84 in
molecule B and 1±84 in molecule D are de®ned in the inhi-
bitor. In the earlier work from this laboratory, ®ve N-terminal
residues and three C-terminal residues of UDG could not be
de®ned. In fact, the N-terminal residue has not been de®ned in
any of the structures reported so far. The structures reported
here, however, involve de®nition of the entire polypeptide
chain.
The Ugi molecule consists of a ®ve-stranded antiparallel
-sheet and two helices, one near the N-terminus and the
other in the polypeptide stretch connecting strands I and II in
the sheet. The N-terminal helix was disordered in the complex
studied earlier in this laboratory, unlike in form II reported
here. Indeed, form II is the only structure in which the entire
polypeptide chain is visualized. The structure of Ugi has been
de®ned, except for the two N-terminal residues, in other
crystals of the UDG±Ugi complex (Putnam et al., 1999). Also
available are the structures of ten crystallographically in-
dependent molecules of free Ugi in two crystal forms (Putnam
et al., 1999). The structures of the bound Ugi in different
crystals of its complex with UDG, including those reported
here, have essentially the same structure. The free Ugi mole-
cules have also a similar structure. However, as pointed out by
Putnam et al. (1999), nine out of the ten free Ugi molecules
have conformational differences at residues Gln19, Glu20 and
Ser21 from the bound ones. These conformational differences
enable Glu20 in the bound molecule to establish an important
interaction with UDG (Putnam et al., 1999).
3.2. DNA binding and domain movement
12 crystal structures containing the EcUDG molecule are
available. As form I of the UDG±Ugi complex reported here
is essentially the same as that reported previously (Ravish-
ankar et al., 1998), albeit with a better resolution, only the
former is considered for further analysis. The 11 structures
contain a total of 20 crystallographically independent enzyme
molecules (Table 3). The r.m.s. deviations in C positions on
their pairwise superposition are listed in Table 4. The devia-
tions are markedly high in the molecule bound to DNA,
indicating considerable conformational changes caused by
interactions with DNA.
UDG is often described as a single-domain enzyme
(Putnam et al., 1999; Parikh, Putnam et al., 2000). The closing
of the active-site cleft subsequent to binding of uracil-
containing DNA has been described as arising from the
clamping motion of active-site loops resulting from concerted
conformational changes in them (Slupphaug et al., 1996;
Table 4
Root-mean-square deviations (AÊ ) among EcUDG molecules in the 11 different crystal forms.
C atoms of all residues were used in the superposition using ALIGN (Cohen, 1997).
UDG±Ugi complex Free UDG±uracil
UDG±
glycerol
UDG±
DNA
Form I Form II 1uug 2uug Free 1eug 4eug 2eug 5eug 3eug 1¯z
B A B C D A B A B A B C D A A A A A A
Form I A 0.24 0.37 0.37 0.38 0.37 0.43 0.40 0.50 0.46 0.59 0.55 0.54 0.57 0.63 0.65 0.65 0.72 0.73 1.48
B 0.38 0.37 0.38 0.37 0.40 0.39 0.49 0.46 0.59 0.57 0.49 0.59 0.64 0.71 0.70 0.77 0.74 1.47
Form II A 0.22 0.20 0.20 0.29 0.32 0.43 0.45 0.47 0.47 0.45 0.49 0.62 0.62 0.61 0.66 0.70 1.41
B 0.19 0.21 0.29 0.32 0.43 0.43 0.47 0.47 0.44 0.48 0.59 0.61 0.59 0.64 0.68 1.40
C 0.19 0.28 0.32 0.42 0.44 0.47 0.47 0.45 0.47 0.60 0.61 0.60 0.65 0.69 1.41
D 0.28 0.33 0.42 0.44 0.46 0.47 0.43 0.49 0.60 0.61 0.60 0.65 0.70 1.41
1uug A 0.21 0.43 0.42 0.54 0.53 0.49 0.56 0.63 0.64 0.62 0.71 0.72 1.41
B 0.44 0.42 0.56 0.53 0.49 0.56 0.64 0.62 0.64 0.73 0.73 1.39
2uug A 0.38 0.54 0.54 0.53 0.57 0.54 0.58 0.55 0.63 0.60 1.39
B 0.53 0.52 0.53 0.56 0.53 0.56 0.55 0.59 0.59 1.40
Free A 0.35 0.33 0.35 0.54 0.56 0.56 0.60 0.61 1.27
B 0.34 0.36 0.54 0.56 0.54 0.60 0.59 1.30
C 0.33 0.53 0.55 0.53 0.60 0.59 1.25
D 0.57 0.60 0.58 0.61 0.63 1.33
1eug A 0.25 0.20 0.21 0.18 1.13
4eug A 0.19 0.18 0.30 1.14
2eug A 0.18 0.30 1.09
5eug A 0.27 1.07
3eug A 1.19
Werner et al., 2000). The DNA complexes of the E. coli and
human enzymes are available (Werner et al., 2000; Slupphaug
et al., 1996; Parikh et al., 1998; Parikh, Walcher et al., 2000).
Their comparison with the corresponding DNA-free enzyme
appeared to indicate that the movement upon complexation
encompassed the whole molecule. To further investigate this
possibility, the difference distance matrices relating DNA-free
and DNA-bound molecules were constructed for the E. coli
and human enzymes. Only residues 6±220 (88±301 in human
enzymes), which are present in all structures, were used in the
calculations. The respective average values of Rij values in the
relevant structures were used in the calculations. The two
difference distance matrices are shown in Fig. 2. The plots
clearly delineate four regions of the molecule, within each of
which the internal movements are minimal. They by and large
appear to move as rigid bodies. Furthermore, the four rigid
regions can be grouped into two pairs, with the two regions in
each pair maintaining their spatial relationship while the pairs
undergo relative movement. Thus, with respect to DNA
binding, the molecule can be divided into two relatively rigid
regions or domains. Careful examination of the difference
distance matrices and the models led to the following deli-
neation of different regions in the molecule.
E. coli UDG: domain 1, 6±76 and 112±150; domain 2, 77±105
and 155±220; link region, 106±111 and 151±154.
Human UDG (values in parentheses indicate the corre-
sponding residues in EcUDG): domain 1, 88±159 (6±78) and
201±235 (120±154); domain 2, 160±191 (79±110) and 240±301
(159±220); link region, 192±200 (111±119) and 236±239
(155±158).
The regions thus delineated in EcUDG are illustrated in Fig. 3.
A rigid-body movement can be described in terms of a
screw motion involving a rotation about and a translation
along an axis. The domain closure subsequent to DNA binding
can be described to a good approximation as the rigid-body
movement of one domain with respect to the other. In order to
quantify the movement, domain 1 of each free EcUDG
molecule of known structure and that in the EcUDG±ssDNA
complex were superposed using ALIGN (Cohen, 1997). A
rotation in the range 8±10 with a negligibly small translation
along an axis passing through the interface between the two
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Figure 2
Difference distance matrix plots obtained by comparing the enzyme
molecules in DNA-free structure and that in the DNA-bound structure.
(a) EcUDG and (b) human UDG. The half above the diagonal contains
positive difference distances, while that below the diagonal contains the
negative difference distances. Lightly shaded regions correspond to a
difference of 1±1.5 AÊ . Regions with differences greater than 1.5 AÊ are
indicated darkly shaded.
Figure 3
Delineation of domains in EcUDG. Domain 1 is in green and domain 2 is
in red. The linker region is in purple. The axis about which the domains
move during closure is also shown.
research papers
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domains was then necessary to bring domain 2 in the two
molecules into superposition (Table 5; Fig. 4). The angle of
rotation is slightly higher in the four molecules in the structure
reported here than in the others, presumably on account of the
somewhat higher ¯exibility afforded by the higher solvent
content in the former.
Extensive information on domain closure is in fact provided
by the complexes involving the human enzyme. Five structures
of the human UDG bound to double-stranded DNA are
available. The rotation and translation during domain closure
in each of these structures with respect to the free molecule
are listed in Table 5. All but one structure (4skn) have
comparable values. In the case of 4skn the rotation angle is 2
lower than that in other structures. The enzyme molecule in
this structure has mutations D145N and L272R. Upon binding
to the substrate, Leu272 penetrates the DNA minor groove,
which is facilitated by the domain closure. It is possible that
the larger side chain of arginine at this position prevents
complete closure.
Although the transformation from the open to the closed
form is substantially a rotation, it does not appear to lend itself
to description as a simple hinge motion. The interface between
the two domains is extensive. It passes through the middle of
the central -sheet. Main-chain hydrogen bonds connect the
two central strands (I and III) in the closed form. The residues
at one end of the strands move apart in the open form so that
the NH of one strand is no longer at a hydrogen-bonding
distance from the CO of the other. A water molecule bridges
the two groups. This water bridge has been observed in all
structures with resolution better than 3 AÊ , including those of
the human and HSV-1 enzymes (Putnam et al., 1999).
In the only available HSV1 UDG±DNA complex, the
enzyme is in the open conformation (Savva et al., 1995). The
molecule is complexed with 50-p-dTdTdT-OH-30. The 30
thymine makes a favourable contact with the mouth of the
uracil pocket but does not enter it (Savva et al., 1995). The
presence of free uracil within the active-site pocket of UDG
does not in itself result in domain closure (Savva et al., 1995;
Xiao et al., 1999). It is not even a necessary condition as an
abasic DNA substrate can induce the closed conformation
(Parikh et al., 1998). The single-stranded trinucleotide induces
domain closure in the E. coli enzyme to nearly the same extent
as the larger double-stranded DNA fragment does in the
human enzyme. Thus, it would appear surprising that a single-
stranded trinucleotide does not induce domain closure in the
viral enzyme. A major difference between the complexes of
E. coli and herpes enzymes is in the location of the tri-
nucleotide in the binding region. In the EcUDG complex with
50-OH-dUAAp-30, the 50dU, which has two nucleotides
towards the 30 end, interacts with the binding pocket. In the
complex of the viral enzyme, however, the location in the
vicinity of the binding pocket is occupied by the 30-terminal
nucleotide. It has been shown previously that a minimum of
two nucleotides are necessary at the 30 side of the uracil at the
binding site for enzyme activity (Varshney & van der Sande,
1991).
In earlier discussions, the emphasis was on concerted
conformational changes of residues and loops at the active site
upon binding of UDG with DNA (Slupphaug et al., 1996;
Werner et al., 2000), although the possibility of two halves of
the enzyme molecule closing in had been suggested (Putnam et
al., 1999). The analyses discussed above,
however, conclusively demonstrate and
quantitatively describe the domain
motion in UDG associated with DNA
binding.
In addition to the inter-domain move-
ment, DNA binding also results in
movements within the domains. The
movement of the 166±171 helix in
EcUDG and the corresponding 247±254
helix in the human enzyme in domain 2 is
particularly pronounced. This helix is on
the protein surface with its N-terminus
forming part of the DNA-binding region.
The interactions of the N-terminus with
Table 5
Domain closure.
(a) Domain closure in E. coli UDG upon binding to ssDNA (1¯z) with respect
to free UDG. See text for details.
Free UDG Rotation () Translation (AÊ )
1eug 8.3 ÿ0.09
2eug 8.2 ÿ0.09
3eug 8.9 ÿ0.09
4eug 8.5 ÿ0.02
5eug 8.0 ÿ0.01
Free A 9.5 ÿ0.06
Free B 9.8 0.01
Free C 9.8 ÿ0.01
Free D 9.8 ÿ0.02
(b) Domain closure in human UDG upon binding to dsDNA with respect to
free UDG (1akz). See text for details.
UDG±dsDNA Rotation () Translation (AÊ )
1ssp 11.3 0.21
2ssp 11.7 0.20
1emj 11.4 0.19
1emh 11.1 0.19
4skn 9.5 0.25
Figure 4
Stereoview illustrating domain closure in EcUDG. Domain 1 of the free enzyme (dark) and that of
the enzyme complexed with single-stranded DNA (light) are superposed. The axis about which
the molecule has to rotate to bring domain 2 into superposition is perpendicular to the ®gure and
is indicated by a ball.
the DNA substrate are presumably responsible for the
movement of the helix on DNA binding. This region of the
structure is well de®ned. In the case of the free structure, the
overall B value (averaged over the four crystallographically
independent molecules) of the helix is 27.4 AÊ 2, compared with
28.6 AÊ 2 for the whole structure. Also, the electron density in
this region is well de®ned.
The parameters required to de®ne the movement of the
helix were obtained through two steps of superposition. In the
®rst step, domain 2 of the DNA-bound structure was super-
posed onto domain 2 of the free structure. In the next step, the
helix in the newly oriented structure was superposed onto the
corresponding helix in the free molecule. The second step
provided the rotation and translation parameters. The helix as
a whole rotates about an axis nearly parallel to the helix axis
by an angle ranging from 7.8 to 10.7. Here again, the angle of
rotation is slightly, though distinctly, higher in the super-
position involving the free molecules in the structure
presented here, perhaps on account of the higher mobility
afforded by the higher solvent content. Although the helix
moves as a whole in response to DNA binding, the helical
parameters themselves remain unchanged (Table 6; Fig. 5a).
A rigid-body movement of the 247±254 helix similar to that
found in EcUDG is also observed in the human enzyme on
DNA binding. Understandably, the movement is smaller in the
DNA complex of the L272R mutant (4skn). The angle of
rotation of the helix in the other complexes has values similar
to that in EcUDG. However, unlike in the case of EcUDG, the
helical parameters also change substantially in the human
enzyme (Table 6; Fig. 5b). In the free molecule, the parameters
correspond to those of an -helix. Upon DNA binding, the
helix winds more tightly, with parameters intermediate
between those of an -helix and a 310 helix. The reason for the
difference between the E. coli and human enzyme in this
regard is not immediately obvious. It might be connected to
the nature and length of the bound DNA. The known struc-
tures of the DNA-bound human enzyme involve 8±10 base-
pair-long double-stranded DNA. The phosphate group of the
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Table 6
Helix motion.
(a) Motion of the 166±171 helix in UDG±DNA complex (1¯z) with respect to
free EcUDGs. See text for details.
Helical parameters
Rotation
()
Translation
(AÊ )
Average
twist ()
Average
N
Average
unit
height (AÊ )
UDG±DNA
1¯z 97.4 3.71 1.52
Free UDG
1eug 8.5 0.02 97.9 3.68 1.44
2eug 8.3 ÿ0.10 98.5 3.66 1.44
3eug 8.8 ÿ0.08 97.9 3.68 1.43
4eug 8.5 ÿ0.22 98.5 3.66 1.46
5eug 7.8 ÿ0.15 98.0 3.67 1.47
Free A 9.6 ÿ0.23 102.1 3.54 1.44
Free B 10.4 ÿ0.09 99.7 3.63 1.50
Free C 10.2 0.02 99.1 3.64 1.49
Free D 10.7 ÿ0.09 97.8 3.69 1.55
(b) Motion of the 247±254 helix in human UDG±DNA complexes with respect
to free UDG (1akz). See text for details.
Helical parameters
Rotation
()
Translation
(AÊ )
Average
twist ()
Average
N
Average
unit
height (AÊ )
Free UDG
1akz 97.6 3.69 1.48
UDG-DNA
1ssp 10.4 ÿ0.44 109.4 3.31 1.83
2ssp 11.9 ÿ0.16 109.9 3.30 1.81
1emh 11.5 ÿ0.57 109.1 3.32 1.84
1emj 10.8 ÿ0.62 109.5 3.31 1.87
4skn 6.4 ÿ0.49 107.2 3.37 1.79
Figure 5
(a) Stereoview of the spatial disposition of the 166±171 helix in free
(green) and DNA-bound (red) EcUDG upon superposition of domain 2
from the respective structures. (b) Similar view in the corresponding 247±
254 helix of human enzyme. See text for details.
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nucleotide two residues away from the uracil inserted into the
binding pocket interacts with residues 246 and 247 in the helix
(Parikh et al., 1998). There is no electron density for the
corresponding phosphate group in the single-stranded tri-
nucleotide bound to EcUDG and the group is presumably
disordered (Werner et al., 2000).
Thus, to summarize, the UDG molecule is made up of two
domains. On DNA binding, the domains move in concert to
close in on the nucleic acid molecule. The binding also results
in movements within the domains.
The diffraction data were collected at the National Area-
Detector Facility supported by Department of Science and
Technology (DST) and the Department of Biotechnology
(DBT). Facilities at the Supercomputer Education Research
Centre (SERC) and the Interactive Graphics Based Molecular
Modelling Facility and the Distributed Information Centre
(both supported by DBT) were used in this work. MBS and
SR were supported by DBT Postdoctoral Research Associa-
teships and KP and PH were recipients of K. S. Krishnan and
Council of Scienti®c and Industrial Research fellowships,
respectively. The work was funded by DST and DBT.
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